Loading…

A mouse model of Zhu-Tokita-Takenouchi-Kim syndrome reveals indispensable SON functions in organ development and hematopoiesis

Rare diseases are underrepresented in biomedical research, leading to insufficient awareness. Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome is a rare disease caused by genetic alterations that result in heterozygous loss of function of SON. While patients with ZTTK syndrome live with numerous symptoms,...

Full description

Saved in:
Bibliographic Details
Published in:JCI insight 2024-03, Vol.9 (5)
Main Authors: Vukadin, Lana, Park, Bohye, Mohamed, Mostafa, Li, Huashi, Elkholy, Amr, Torrelli-Diljohn, Alex, Kim, Jung-Hyun, Jeong, Kyuho, Murphy, James M, Harvey, Caitlin A, Dunlap, Sophia, Gehrs, Leah, Lee, Hanna, Kim, Hyung-Gyoon, Sah, Jay Prakash, Lee, Seth N, Stanford, Denise, Barrington, Robert A, Foote, Jeremy B, Sorace, Anna G, Welner, Robert S, Hildreth, 3rd, Blake E, Lim, Ssang-Taek Steve, Ahn, Eun-Young Erin
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rare diseases are underrepresented in biomedical research, leading to insufficient awareness. Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome is a rare disease caused by genetic alterations that result in heterozygous loss of function of SON. While patients with ZTTK syndrome live with numerous symptoms, the lack of model organisms hampers our understanding of SON and this complex syndrome. Here, we developed Son haploinsufficiency (Son+/-) mice as a model of ZTTK syndrome and identified the indispensable roles of Son in organ development and hematopoiesis. Son+/- mice recapitulated clinical symptoms of ZTTK syndrome, including growth retardation, cognitive impairment, skeletal abnormalities, and kidney agenesis. Furthermore, we identified hematopoietic abnormalities in Son+/- mice, including leukopenia and immunoglobulin deficiency, similar to those observed in human patients. Surface marker analyses and single-cell transcriptome profiling of hematopoietic stem and progenitor cells revealed that Son haploinsufficiency shifted cell fate more toward the myeloid lineage but compromised lymphoid lineage development by reducing genes required for lymphoid and B cell lineage specification. Additionally, Son haploinsufficiency caused inappropriate activation of erythroid genes and impaired erythropoiesis. These findings highlight the importance of the full gene expression of Son in multiple organs. Our model serves as an invaluable research tool for this rare disease and related disorders associated with SON dysfunction.
ISSN:2379-3708
2379-3708
DOI:10.1172/jci.insight.175053